New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 29, 2012
10:21 EDTPSS, NS, CVC, CERS, PAA, CVX, RWC, EEP, WMBOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Chevron (CVX) upgraded to Buy from Hold at Deutsche Bank...Cablevision (CVC) upgraded to Buy from Neutral at Miller Tabak...Williams (WMB) upgraded to Conviction Buy from Buy at Goldman...Plains All American (PAA) upgraded to Buy from Neutral at Goldman...NuStar Energy (NS) upgraded to Neutral from Sell at Goldman...Enbridge Energy (EEP) upgraded to Neutral from Sell at Goldman...Cerus (CERS) upgraded to Outperform from Neutral at RW Baird...Collective Brands (PSS) upgraded to Above Average from Average at Caris...Rowan Companies (RWC) upgraded to Buy from Neutral at Pritchard.
News For CVX;CVC;WMB;PAA;NS;EEP;CERS;PSS;RWC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 16, 2014
16:45 EDTCERSCerus up 28.7% after FDA approves Intercept Blood System
Subscribe for More Information
16:44 EDTCERSCerus Intercept Blood System approved by FDA
The FDA approved the Intercept Blood System for plasma, the first pathogen reduction system for use by blood establishments in the preparation of plasma in order to reduce the risk of transfusion-transmitted infections, or TTI. The Intercept Blood System for plasma may be used to reduce pathogens in plasma derived from whole blood and plasma obtained by apheresis, a collection process that separates red blood cells from plasma and then returns the red cells to the donor. Examples of some of the pathogens that may be reduced using the Intercept Blood System include HIV, hepatitis B and C viruses and West Nile virus. The adverse events experienced by patients who received plasma prepared using the Intercept Blood System for plasma were comparable to those experienced by participants who received plasma that had not been treated with the pathogen reduction device. The Intercept Blood System for plasma is marketed by Cerus. Reference Link
December 15, 2014
16:35 EDTRWCRelm Wireless receives $2.9M in orders from U.S. Forest Service
Subscribe for More Information
15:39 EDTCVXChevron said to plan to pull out of Ukraine gas deal, Reuters reports
Subscribe for More Information
December 14, 2014
17:07 EDTCVXOPEC's Badri says group will withstand oil price fall, Reuters says
Subscribe for More Information
December 12, 2014
14:46 EDTCVXChevron volatility elevated as shares trend lower
Subscribe for More Information
06:51 EDTCVXBrent crude oil fell to five year low, Reuters reports
Subscribe for More Information
05:45 EDTWMBStocks with implied volatility movement; WMB VXX
Subscribe for More Information
December 11, 2014
05:44 EDTCVXStocks with implied volatility movement; CZR CVX
Stocks with implied volatility movement; Caesar's (CZR) 126, Chevron (CVX) 33 according to iVolatility.
December 10, 2014
16:44 EDTCVXOn The Fly: Closing Wrap
Subscribe for More Information
16:00 EDTCVXOptions Update; December 10, 2014
Subscribe for More Information
09:36 EDTCVXActive equity options trading
Subscribe for More Information
December 9, 2014
18:09 EDTCVXChevron FY15 CapEx plan delayed until 2015, Bloomberg says
Due to the recent slump in crude oil, Chevron will delay the release of its 2015 capital expenditure plan until early 2015, Bloomberg reports, citing a telephone interview with a company spokesperson. Reference Link
12:30 EDTEEPWells Fargo to hold a symposium
Subscribe for More Information
December 8, 2014
19:01 EDTCVXChevron subsidiary acquires three blocks offshore New Zealand
Subscribe for More Information
10:00 EDTEEPOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Antero Resources (AR) upgraded to Buy from Neutral at Citigroup... Apache (APA) upgraded to Buy from Neutral at Citigroup... Applied Materials (AMAT) upgraded to Buy from Hold at Deutsche Bank... Arch Capital (ACGL) upgraded to Outperform from Market Perform at BMO Capital... CU Bancorp (CUNB) upgraded to Buy from Hold at Sandler O'Neill... Calpine (CPN) upgraded to Outperform from Neutral at Macquarie... Commerzbank (CRZBY) upgraded to Market Perform from Underperform at Keefe Bruyette... EastGroup Properties (EGP) upgraded to Neutral from Underperform at Credit Suisse... Enbridge Energy Management (EEQ) upgraded to Equal Weight at Morgan Stanley... Enbridge Energy (EEP) upgraded to Equal Weight from Underweight at Morgan Stanley... GasLog (GLOG) upgraded to Buy from Hold at Stifel... Hoegh LNG (HMLP) upgraded to Buy from Neutral at UBS... Illinois Tool Works (ITW) upgraded to Buy from Accumulate at Global Hunter... LaSalle Hotel (LHO) upgraded at Morgan Stanley... Lufthansa (DLAKY) upgraded to Buy from Neutral at Nomura... NASDAQ (NDAQ) upgraded to Outperform from Market Perform at Keefe Bruyette... Newfield Exploration (NFX) upgraded to Buy from Neutral at Citigroup... Omega Healthcare (OHI) upgraded to Buy from Hold at Jefferies... Orange SA (ORAN) upgraded to Conviction Buy from Neutral at Goldman... SM Energy (SM) upgraded to Outperform from Market Perform at BMO Capital... Southwest (LUV) upgraded at Goldman... TSMC (TSM) upgraded to Buy from Neutral at BofA/Merrill... United Technologies (UTX) upgraded at Bernstein... eBay (EBAY) upgraded to Buy from Hold at Stifel.
08:00 EDTEEPEnbridge Energy upgraded to Equal Weight from Underweight at Morgan Stanley
Morgan Stanley upgraded Enbridge Energy to Equal Weight from Underweight based on an improved distribution growth outlook. Price target raised to $47 from $38.
07:53 EDTCVXClimate for Exxon E&P acquisition improved by falling prices, WSJ says
Subscribe for More Information
December 5, 2014
11:17 EDTCVXPhillips 66 announces 2015 capital budget of $4.6B
Subscribe for More Information
07:43 EDTCVXLondon bankers see oil slump spurring energy industry consolidation, WSJ reports
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use